Description: International Biotechnology Trust plc is an investment trust company. The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies, which may be quoted or unquoted and whose shares are considered to have growth prospects, with experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. It may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Investments may also be made in related sectors, such as medical devices and healthcare services. Its portfolio is split between large, mid and small-capitalization companies, primarily quoted on stock exchanges in North America. Its investment manager is SV Life Sciences Managers LLP.
Home Page: www.internationalbiotrust.com
IBT Technical Analysis
71 Kingsway
London,
WC2B 6ST
United Kingdom
Phone:
NA
Officers
| Name | Title |
|---|---|
| Ms. Lucy Costa Duarte | Head of Investor Relations |
| Ms. Catherine Elizabeth Bingham M.B.A. | Managing Partner |
| Ms. Ailsa Craig | Investment Mang. |
| Mr. Marek Poszepczynski M Sci Eng | Investment Mang. |
| Claire Jackson | Company Sec. |
| Dr. Carl Harald Janson | Lead Investment Mang. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.993 |
| Price-to-Sales TTM: | 8.003 |
| IPO Date: | |
| Fiscal Year End: | August |
| Full Time Employees: | 0 |